Presenters: Anthony Fauci, MD; John G. Bartlett, MD; Julio S. G. Montaner, MD, FRCPC, FCCP; Roy Gulick, MD; Margaret Fischl, MD
Related implications for enhancing quality of life during combination therapy; approved drugs in the next six months by the FDA; be able to discuss major issues in antiretroviral therapy; define expectations for managing & treating HIV/AIDS; Describe differences in virologic responses using strategies of imultaneous/sequential initiation of three drug antiretrovial therapy; demonstrate reasons for differences in virologic responses using those therapies.
|